# Effect of Genetic and Epigenetic Factors on the Clinical Response and Toxicity to Cisplatin Among Egyptian Non-small Cell Lung Cancer Patients

> **NCT05746598** · — · UNKNOWN · sponsor: **Ain Shams University** · enrollment: 178 (estimated)

## Conditions studied

- Non Small Cell Lung Cancer
- Nephropathy
- Cardiotoxicity

## Interventions

- **DRUG:** Cisplatin injection

## Key facts

- **NCT ID:** NCT05746598
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-07-01
- **Primary completion:** 2023-03-01
- **Final completion:** 2023-04-01
- **Target enrollment:** 178 (ESTIMATED)
- **Last updated:** 2023-02-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05746598

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05746598, "Effect of Genetic and Epigenetic Factors on the Clinical Response and Toxicity to Cisplatin Among Egyptian Non-small Cell Lung Cancer Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05746598. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*